Published in JAMA on March 13, 1987
Diagnosis and treatment of acute or persistent diarrhea. Gastroenterology (2009) 1.35
Binding and killing of bacteria by bismuth subsalicylate. Antimicrob Agents Chemother (1989) 1.08
Prevention and self-treatment of traveler's diarrhea. Clin Microbiol Rev (2006) 1.05
Binding of bismuth to cell components: clue to mode of action and side effects. CMAJ (1987) 0.91
ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults. Am J Gastroenterol (2016) 0.90
Antimicrobial activity of bismuth subsalicylate on Clostridium difficile, Escherichia coli O157:H7, norovirus, and other common enteric pathogens. Gut Microbes (2015) 0.86
New Developments in Traveler's Diarrhea. Gastroenterol Hepatol (N Y) (2011) 0.86
The inhibitory effect of colloidal bismuth hydroxide gel on Escherichia coli O157:H7 and on the activity of Shiga toxins. BMC Res Notes (2014) 0.84
Update on Traveler's Diarrhea. Curr Infect Dis Rep (2002) 0.83
Optimal dosing of trimethoprim-sulfamethoxazole when used with loperamide to treat traveler's diarrhea. Antimicrob Agents Chemother (1992) 0.78
President's address: travel medicine and principles of safe travel. Trans Am Clin Climatol Assoc (2008) 0.75
Travellers' diarrhea in children. Paediatr Child Health (2003) 0.75
Pathogen-induced secretory diarrhea and its prevention. Eur J Clin Microbiol Infect Dis (2016) 0.75
Pathogenesis of Escherichia coli diarrhea. N Engl J Med (1971) 10.36
Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N Engl J Med (1997) 5.88
Detection and characterization of colonization factor of enterotoxigenic Escherichia coli isolated from adults with diarrhea. Infect Immun (1978) 5.71
Typhoid fever: pathogenesis and immunologic control. N Engl J Med (1970) 4.95
Hemagglutination patterns of enterotoxigenic and enteropathogenic Escherichia coli determined with human, bovine, chicken, and guinea pig erythrocytes in the presence and absence of mannose. Infect Immun (1979) 4.60
Infections due to gram-negative organisms: an analysis of 860 patients with bacteremia at the University of Minnesota Medical Center, 1958-1966. Medicine (Baltimore) (1969) 4.20
Infantile diarrhea produced by heat-stable enterotoxigenic Escherichia coli. N Engl J Med (1976) 3.82
Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer (1997) 3.58
Prevention and treatment of traveler's diarrhea. N Engl J Med (1993) 3.54
Pathogenesis of Shigella dysenteriae 1 (Shiga) dysentery. J Infect Dis (1973) 3.45
Inactivation of Norwalk virus in drinking water by chlorine. Appl Environ Microbiol (1985) 3.12
Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers. J Infect Dis (1974) 3.10
Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world. Clin Infect Dis (2001) 3.08
Patterns of loss of enterotoxigenicity by Escherichia coli isolated from adults with diarrhea: suggestive evidence for an interrelationship with serotype. Infect Immun (1977) 3.04
A newly recognized cause of travelers' diarrhea: enteroadherent Escherichia coli. J Infect Dis (1985) 2.94
Comparative susceptibility of latin american and united states students to enteric pathogens. N Engl J Med (1976) 2.94
Differences in serological responses and excretion patterns of volunteers challenged with enterotoxigenic Escherichia coli with and without the colonization factor antigen. Infect Immun (1978) 2.78
Economic healthcare costs of Clostridium difficile infection: a systematic review. J Hosp Infect (2010) 2.77
Treatment of travelers' diarrhea with trimethoprim/sulfamethoxazole and with trimethoprim alone. N Engl J Med (1982) 2.71
Cerebral cavernous malformations. Incidence and familial occurrence. N Engl J Med (1988) 2.65
Virulence of three distinct Cryptosporidium parvum isolates for healthy adults. J Infect Dis (1999) 2.65
Role of Escherichia coli colonisation factor antigen in acute diarrhoea. Lancet (1978) 2.65
Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults. J Infect Dis (1990) 2.63
Typhoid fever: pathogenesis and immunologic control. 2. N Engl J Med (1970) 2.63
Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine. J Infect Dis (1977) 2.57
Adverse effect of lomotil therapy in shigellosis. JAMA (1973) 2.57
Virulence factors of enterotoxigenic Escherichia coli. J Infect Dis (1977) 2.45
Epidemiologic studies of an outbreak of nosocomial methicillin-resistant Staphylococcus aureus infections. Infect Control (1981) 2.43
Comparison of two assay methods for patterns of adherence to HEp-2 cells of Escherichia coli from patients with diarrhea. J Clin Microbiol (1990) 2.43
The isolation and characterization of a Norwalk virus-specific cDNA. J Clin Invest (1991) 2.42
Pathogenicity of enteroadherent Escherichia coli in adult volunteers. J Infect Dis (1986) 2.32
Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. J Hosp Infect (2008) 2.30
Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection. J Infect Dis (1972) 2.29
Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole. N Engl J Med (1982) 2.27
Diarrhea caused by Shigella, rotavirus, and Giardia in day-care centers: prospective study. J Pediatr (1981) 2.21
Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens. Antimicrob Agents Chemother (1983) 2.20
Prevention of traveler's diarrhea (emporiatric enteritis). Prophylactic administration of subsalicylate bismuth). JAMA (1980) 2.16
A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis (1999) 2.14
Alopecia associated with fluconazole therapy. Ann Intern Med (1995) 2.05
Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea. A placebo-controlled, randomized trial. Ann Intern Med (1987) 2.05
Facial neuromuscular retraining for oral synkinesis. Plast Reconstr Surg (1997) 1.97
The response of man to virulent Shigella flexneri 2a. J Infect Dis (1969) 1.97
Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations. Stroke (1987) 1.96
The MRI appearance of cavernous malformations (angiomas). J Neurosurg (1987) 1.93
Detection of enteric viruses in treated drinking water. Appl Environ Microbiol (1984) 1.87
Autoregulation of blood flow. Circ Res (1986) 1.84
Compliance with universal precautions among health care workers at three regional hospitals. Am J Infect Control (1995) 1.83
Prospective study of enteropathogens in children with diarrhea in Houston and Mexico. J Pediatr (1978) 1.82
Occurrence of Giardia lamblia in children in day care centers. J Pediatr (1984) 1.82
Immunity in typhoid fever: evaluation of live streptomycin-dependent vaccine. Antimicrob Agents Chemother (Bethesda) (1970) 1.82
Treatment of falciparum malaria caused by strain resistant to quinine. JAMA (1970) 1.81
Lack of correlation between known virulence properties of Aeromonas hydrophila and enteropathogenicity for humans. Infect Immun (1985) 1.80
Clinical approach to infectious diarrheas. Medicine (Baltimore) (1973) 1.75
Production of heat-stable, methanol-soluble enterotoxin by Yersinia enterocolitica. Infect Immun (1979) 1.73
Risk and aetiology of diarrhoea at various tourist destinations. Lancet (2000) 1.72
The variable MR appearance of primary lymphoma of the central nervous system: comparison with histopathologic features. AJNR Am J Neuroradiol (1997) 1.69
Cryptosporidium, isospora and strongyloides in AIDS. Natl Med J India (1996) 1.67
Effect of erythrocyte aggregation on velocity profiles in venules. Am J Physiol Heart Circ Physiol (2001) 1.66
Changes in facial movement after maxillary osteotomies. J Oral Maxillofac Surg (1997) 1.66
Enteropathogenic Escherichia coli: lack of correlation of serotype with pathogenicity. J Infect Dis (1976) 1.65
Outbreaks of diarrhea associated with Clostridium difficile and its toxin in day-care centers: evidence of person-to-person spread. J Pediatr (1983) 1.63
The antibody response to 27-, 17-, and 15-kDa Cryptosporidium antigens following experimental infection in humans. J Infect Dis (1998) 1.61
Susceptibility and serologic response of healthy adults to reinfection with Cryptosporidium parvum. Infect Immun (1998) 1.59
A simple method for concentration of enteroviruses and rotaviruses from cell culture harvests using membrane filters. Intervirology (1978) 1.58
The relation between production of cytotoxin and clinical features in shigellosis. J Infect Dis (1986) 1.54
Enteropathogens associated with pediatric diarrhea in Mexico City. J Pediatr (1977) 1.53
Choroid plexus carcinoma in siblings: a study by light and electron microscopy with Ki-67 immunocytochemistry. J Neuropathol Exp Neurol (1989) 1.52
Measurement of ionized calcium in blood platelets with the photoprotein aequorin. Comparison with Quin 2. J Biol Chem (1985) 1.49
Erythrocyte velocity measurement in microvessels by a two-slit photometric method. J Appl Physiol (1967) 1.49
False aneurysm associated with rupture of an arteriovenous malformation--implications for treatment: case report. Neurosurgery (1993) 1.47
Microvascular and tissue oxygen gradients in the rat mesentery. Proc Natl Acad Sci U S A (1998) 1.46
Fecal leukocytes in enteric infections. Am J Clin Pathol (1977) 1.44
Acquired toxoplasmosis. A neglected cause of treatable nervous system disease. Arch Neurol (1975) 1.44
Evaluation of new anti-infective drugs for the treatment of gastritis and peptic ulcer disease associated with infection by Helicobacter pylori. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis (1992) 1.44
Emergence of resistant fecal Escherichia coli in travelers not taking prophylactic antimicrobial agents. Antimicrob Agents Chemother (1990) 1.43
Survival and detection of rotaviruses on environmental surfaces in day care centers. Appl Environ Microbiol (1983) 1.43
Use of antimicrobial agents in animal feeds: implications for human health. Rev Infect Dis (1987) 1.43
Cryptosporidium parvum: intensity of infection and oocyst excretion patterns in healthy volunteers. J Infect Dis (1996) 1.43
Transmission dynamics of enteric bacteria in day-care centers. Am J Epidemiol (1983) 1.43
Papillary carcinoma of the thyroid: additional evidence in support of a familial component. Cancer Invest (1989) 1.42
Viral shedding and fecal IgA response after Norwalk virus infection. J Infect Dis (1995) 1.41
Reovirus-like agent and enterotoxigenic Escherichia coli infections in pediatric diarrhea in the Philippines. J Infect Dis (1978) 1.41
Molecular characterization of strains of enteroinvasive Escherichia coli O143, including isolates from a large outbreak in Houston, Texas. J Clin Microbiol (1992) 1.41
Red blood cell mass and plasma volume changes in manned space flight. JAMA (1967) 1.41
Shigellosis in custodial institutions. Am J Epidemiol (1970) 1.40